BBC vs. CANC ETF Comparison
Comparison of Virtus LifeSci Biotech Clinical Trials ETF (BBC) to Tema Oncology ETF (CANC)
BBC
Virtus LifeSci Biotech Clinical Trials ETF
BBC Description
The Fund seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index, which tracks the performance of select clinical trials stage biotechnology companies.
Grade (RS Rating)
Last Trade
$24.58
Average Daily Volume
3,076
Number of Holdings
*
101
* may have additional holdings in another (foreign) market
CANC
Tema Oncology ETF
CANC Description
Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology. The fund is non-diversified.Grade (RS Rating)
Last Trade
$26.75
Average Daily Volume
20,682
Number of Holdings
*
8
* may have additional holdings in another (foreign) market
Performance
| Period | BBC | CANC |
|---|---|---|
| 30 Days | -9.81% | -1.04% |
| 60 Days | -11.86% | -2.97% |
| 90 Days | -9.09% | -0.82% |
| 12 Months | 2.94% |
1 Overlapping Holdings
| Symbol | Grade | Weight in BBC | Weight in CANC | Overlap | |
|---|---|---|---|---|---|
| RVMD | D | 0.88% | 2.85% | 0.88% |
BBC Overweight 100 Positions Relative to CANC
| Symbol | Grade | Weight | |
|---|---|---|---|
| NRIX | C | 1.12% | |
| MORF | C | 1.09% | |
| IRON | C | 1.02% | |
| CELC | B | 0.97% | |
| PHVS | F | 0.97% | |
| RCKT | F | 0.94% | |
| ARQT | B | 0.93% | |
| NUVB | D | 0.92% | |
| NUVL | C | 0.92% | |
| LBPH | B | 0.92% | |
| IMVT | F | 0.92% | |
| PCVX | B | 0.91% | |
| DYN | C | 0.91% | |
| SLN | D | 0.91% | |
| DNLI | C | 0.91% | |
| ARWR | C | 0.91% | |
| CLDX | D | 0.9% | |
| CYTK | D | 0.9% | |
| ANAB | B | 0.89% | |
| MRUS | C | 0.89% | |
| SMMT | C | 0.89% | |
| RXRX | F | 0.89% | |
| PRTA | F | 0.88% | |
| XENE | F | 0.88% | |
| RNA | C | 0.88% | |
| ELVN | C | 0.88% | |
| JANX | D | 0.88% | |
| PGEN | C | 0.88% | |
| BEAM | D | 0.87% | |
| ACLX | B | 0.87% | |
| ABUS | B | 0.87% | |
| BLTE | C | 0.87% | |
| SAVA | F | 0.87% | |
| VRDN | F | 0.87% | |
| EWTX | C | 0.87% | |
| KURA | D | 0.86% | |
| ERAS | C | 0.86% | |
| AKRO | D | 0.86% | |
| CRNX | D | 0.86% | |
| MLYS | D | 0.86% | |
| OLMA | D | 0.85% | |
| VERA | D | 0.85% | |
| RGNX | F | 0.85% | |
| SNDX | D | 0.85% | |
| ALLO | F | 0.85% | |
| IDYA | F | 0.84% | |
| RCUS | F | 0.84% | |
| REPL | D | 0.84% | |
| VERV | F | 0.84% | |
| SVRA | D | 0.84% | |
| MGNX | F | 0.83% | |
| VKTX | D | 0.83% | |
| KROS | F | 0.83% | |
| PTGX | B | 0.83% | |
| NTLA | F | 0.83% | |
| ARVN | F | 0.83% | |
| COGT | C | 0.83% | |
| IMTX | C | 0.83% | |
| EDIT | F | 0.82% | |
| XNCR | F | 0.82% | |
| TERN | C | 0.82% | |
| PLRX | F | 0.82% | |
| LQDA | D | 0.82% | |
| CNTA | D | 0.81% | |
| ITOS | D | 0.81% | |
| FDMT | D | 0.81% | |
| CGON | F | 0.81% | |
| HLVX | D | 0.8% | |
| ALEC | F | 0.8% | |
| CVAC | F | 0.8% | |
| VIR | F | 0.8% | |
| KYMR | D | 0.8% | |
| CMPS | D | 0.79% | |
| ORIC | F | 0.79% | |
| RLAY | F | 0.78% | |
| TYRA | D | 0.77% | |
| SRRK | F | 0.77% | |
| IGMS | F | 0.77% | |
| APLT | D | 0.76% | |
| ETNB | F | 0.76% | |
| QURE | F | 0.76% | |
| ARCT | F | 0.75% | |
| ABCL | F | 0.74% | |
| BCYC | F | 0.74% | |
| STOK | D | 0.72% | |
| LYEL | F | 0.71% | |
| ALXO | F | 0.7% | |
| ANNX | D | 0.69% | |
| FULC | F | 0.69% | |
| AUTL | F | 0.69% | |
| CGEM | D | 0.68% | |
| SANA | F | 0.68% | |
| PRME | F | 0.67% | |
| WVE | D | 0.66% | |
| IMNM | F | 0.65% | |
| LRMR | D | 0.65% | |
| TSHA | F | 0.53% | |
| CABA | F | 0.52% | |
| ZNTL | F | 0.4% | |
| AVTE | F | 0.05% |
BBC: Top Represented Industries & Keywords
CANC: Top Represented Industries & Keywords
Compare ETFs
